Issues to Be Addressed and Hopefully Resolved in the Carotid Revascularization Endarterectomy Versus Stenting Trial 2

The superiority of carotid endarterectomy (CEA) plus best medical treatment (BMT) over BMT alone for the management of patients with asymptomatic carotid stenosis is based on randomized controlled trials that recruited patients up to 30 years ago. Best medical treatment has improved considerably sin...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Angiology 2016-05, Vol.67 (5), p.408-410
1. Verfasser:	Moore, Wesley S.
Format:	Artikel
Sprache:	eng
Schlagworte:	Angioplasty - methods Carotid Arteries - surgery Carotid Stenosis - therapy Endarterectomy, Carotid Humans Stents Treatment Outcome
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

container_end_page	410
container_issue	5
container_start_page	408
container_title	Angiology
container_volume	67
creator	Moore, Wesley S.
description	The superiority of carotid endarterectomy (CEA) plus best medical treatment (BMT) over BMT alone for the management of patients with asymptomatic carotid stenosis is based on randomized controlled trials that recruited patients up to 30 years ago. Best medical treatment has improved considerably since that time with respect to stroke prevention. Furthermore, a new carotid intervention has emerged during the last 2 decades and has gradually become established, that is, carotid artery stenting (CAS). Consequently, the efficacy of current BMT alone needs to be compared not only with CEA plus BMT but also with CAS plus BMT to determine which strategy achieves the optimal stroke prevention rates. This article highlights the purpose of the Carotid Revascularization Endarterectomy versus Stenting Trial (CREST) 2 and discusses the issues that CREST-2 will hopefully provide answers to.
doi_str_mv	10.1177/0003319715611281
format	Article
fullrecord	<record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1781536367</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sage_id>10.1177_0003319715611281</sage_id><sourcerecordid>1781536367</sourcerecordid><originalsourceid>FETCH-LOGICAL-c337t-b640c8ba662168a054231f2b7621da00a19515b099b652d31ca70337f3b7f1c23</originalsourceid><addsrcrecordid>eNp1UMtKxDAUDaLo-Ni7kizdVHOTNpkudfAFguBrW9LmViudZsxNhfHrzTDqQnB1Ofc84BzGDkGcABhzKoRQCkoDhQaQU9hgEyhzkUFh8k02WdHZit9hu0RvCRYg9DbbkTrXQkkzYeMN0YjEo-fnyM-cC0iEjtvB8Wu_wHbs-yW_R_L9R3p3A4-vyGc2-Ni59P-w1Iy9Dd2njZ0f-MXgbIgYsIl-vuTPGGgk_hBxiN3wwh9DZ3su99lWa3vCg--7x54uLx5n19nt3dXN7Ow2a5QyMat1LpppbbWWoKdWFLlU0MraJOysEBbKAopalGWtC-kUNNakQUyratNCI9UeO17nLoJ_TzVjNe-owb63A_qRKjBTKJRW2iSpWEub4IkCttUidHMblhWIajV29XfsZDn6Th_rObpfw8-6SZCtBWRfsHrzYxhS2_8DvwC8kIYs</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1781536367</pqid></control><display><type>article</type><title>Issues to Be Addressed and Hopefully Resolved in the Carotid Revascularization Endarterectomy Versus Stenting Trial 2</title><source>Access via SAGE</source><source>MEDLINE</source><creator>Moore, Wesley S.</creator><contributor>Paraskevas, Kosmas I ; Veith, Frank J ; Mikhailidis, Dimitri P</contributor><creatorcontrib>Moore, Wesley S. ; Paraskevas, Kosmas I ; Veith, Frank J ; Mikhailidis, Dimitri P</creatorcontrib><description>The superiority of carotid endarterectomy (CEA) plus best medical treatment (BMT) over BMT alone for the management of patients with asymptomatic carotid stenosis is based on randomized controlled trials that recruited patients up to 30 years ago. Best medical treatment has improved considerably since that time with respect to stroke prevention. Furthermore, a new carotid intervention has emerged during the last 2 decades and has gradually become established, that is, carotid artery stenting (CAS). Consequently, the efficacy of current BMT alone needs to be compared not only with CEA plus BMT but also with CAS plus BMT to determine which strategy achieves the optimal stroke prevention rates. This article highlights the purpose of the Carotid Revascularization Endarterectomy versus Stenting Trial (CREST) 2 and discusses the issues that CREST-2 will hopefully provide answers to.</description><identifier>ISSN: 0003-3197</identifier><identifier>EISSN: 1940-1574</identifier><identifier>DOI: 10.1177/0003319715611281</identifier><identifier>PMID: 26460327</identifier><language>eng</language><publisher>Los Angeles, CA: SAGE Publications</publisher><subject>Angioplasty - methods ; Carotid Arteries - surgery ; Carotid Stenosis - therapy ; Endarterectomy, Carotid ; Humans ; Stents ; Treatment Outcome</subject><ispartof>Angiology, 2016-05, Vol.67 (5), p.408-410</ispartof><rights>The Author(s) 2015</rights><rights>The Author(s) 2015.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c337t-b640c8ba662168a054231f2b7621da00a19515b099b652d31ca70337f3b7f1c23</citedby><cites>FETCH-LOGICAL-c337t-b640c8ba662168a054231f2b7621da00a19515b099b652d31ca70337f3b7f1c23</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://journals.sagepub.com/doi/pdf/10.1177/0003319715611281$$EPDF$$P50$$Gsage$$H</linktopdf><linktohtml>$$Uhttps://journals.sagepub.com/doi/10.1177/0003319715611281$$EHTML$$P50$$Gsage$$H</linktohtml><link.rule.ids>314,780,784,21819,27924,27925,43621,43622</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/26460327$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><contributor>Paraskevas, Kosmas I</contributor><contributor>Veith, Frank J</contributor><contributor>Mikhailidis, Dimitri P</contributor><creatorcontrib>Moore, Wesley S.</creatorcontrib><title>Issues to Be Addressed and Hopefully Resolved in the Carotid Revascularization Endarterectomy Versus Stenting Trial 2</title><title>Angiology</title><addtitle>Angiology</addtitle><description>The superiority of carotid endarterectomy (CEA) plus best medical treatment (BMT) over BMT alone for the management of patients with asymptomatic carotid stenosis is based on randomized controlled trials that recruited patients up to 30 years ago. Best medical treatment has improved considerably since that time with respect to stroke prevention. Furthermore, a new carotid intervention has emerged during the last 2 decades and has gradually become established, that is, carotid artery stenting (CAS). Consequently, the efficacy of current BMT alone needs to be compared not only with CEA plus BMT but also with CAS plus BMT to determine which strategy achieves the optimal stroke prevention rates. This article highlights the purpose of the Carotid Revascularization Endarterectomy versus Stenting Trial (CREST) 2 and discusses the issues that CREST-2 will hopefully provide answers to.</description><subject>Angioplasty - methods</subject><subject>Carotid Arteries - surgery</subject><subject>Carotid Stenosis - therapy</subject><subject>Endarterectomy, Carotid</subject><subject>Humans</subject><subject>Stents</subject><subject>Treatment Outcome</subject><issn>0003-3197</issn><issn>1940-1574</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp1UMtKxDAUDaLo-Ni7kizdVHOTNpkudfAFguBrW9LmViudZsxNhfHrzTDqQnB1Ofc84BzGDkGcABhzKoRQCkoDhQaQU9hgEyhzkUFh8k02WdHZit9hu0RvCRYg9DbbkTrXQkkzYeMN0YjEo-fnyM-cC0iEjtvB8Wu_wHbs-yW_R_L9R3p3A4-vyGc2-Ni59P-w1Iy9Dd2njZ0f-MXgbIgYsIl-vuTPGGgk_hBxiN3wwh9DZ3su99lWa3vCg--7x54uLx5n19nt3dXN7Ow2a5QyMat1LpppbbWWoKdWFLlU0MraJOysEBbKAopalGWtC-kUNNakQUyratNCI9UeO17nLoJ_TzVjNe-owb63A_qRKjBTKJRW2iSpWEub4IkCttUidHMblhWIajV29XfsZDn6Th_rObpfw8-6SZCtBWRfsHrzYxhS2_8DvwC8kIYs</recordid><startdate>201605</startdate><enddate>201605</enddate><creator>Moore, Wesley S.</creator><general>SAGE Publications</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>201605</creationdate><title>Issues to Be Addressed and Hopefully Resolved in the Carotid Revascularization Endarterectomy Versus Stenting Trial 2</title><author>Moore, Wesley S.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c337t-b640c8ba662168a054231f2b7621da00a19515b099b652d31ca70337f3b7f1c23</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2016</creationdate><topic>Angioplasty - methods</topic><topic>Carotid Arteries - surgery</topic><topic>Carotid Stenosis - therapy</topic><topic>Endarterectomy, Carotid</topic><topic>Humans</topic><topic>Stents</topic><topic>Treatment Outcome</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Moore, Wesley S.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Angiology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Moore, Wesley S.</au><au>Paraskevas, Kosmas I</au><au>Veith, Frank J</au><au>Mikhailidis, Dimitri P</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Issues to Be Addressed and Hopefully Resolved in the Carotid Revascularization Endarterectomy Versus Stenting Trial 2</atitle><jtitle>Angiology</jtitle><addtitle>Angiology</addtitle><date>2016-05</date><risdate>2016</risdate><volume>67</volume><issue>5</issue><spage>408</spage><epage>410</epage><pages>408-410</pages><issn>0003-3197</issn><eissn>1940-1574</eissn><abstract>The superiority of carotid endarterectomy (CEA) plus best medical treatment (BMT) over BMT alone for the management of patients with asymptomatic carotid stenosis is based on randomized controlled trials that recruited patients up to 30 years ago. Best medical treatment has improved considerably since that time with respect to stroke prevention. Furthermore, a new carotid intervention has emerged during the last 2 decades and has gradually become established, that is, carotid artery stenting (CAS). Consequently, the efficacy of current BMT alone needs to be compared not only with CEA plus BMT but also with CAS plus BMT to determine which strategy achieves the optimal stroke prevention rates. This article highlights the purpose of the Carotid Revascularization Endarterectomy versus Stenting Trial (CREST) 2 and discusses the issues that CREST-2 will hopefully provide answers to.</abstract><cop>Los Angeles, CA</cop><pub>SAGE Publications</pub><pmid>26460327</pmid><doi>10.1177/0003319715611281</doi><tpages>3</tpages></addata></record>
fulltext	fulltext
identifier	ISSN: 0003-3197
ispartof	Angiology, 2016-05, Vol.67 (5), p.408-410
issn	0003-3197 1940-1574
language	eng
recordid	cdi_proquest_miscellaneous_1781536367
source	Access via SAGE; MEDLINE
subjects	Angioplasty - methods Carotid Arteries - surgery Carotid Stenosis - therapy Endarterectomy, Carotid Humans Stents Treatment Outcome
title	Issues to Be Addressed and Hopefully Resolved in the Carotid Revascularization Endarterectomy Versus Stenting Trial 2
url	https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-21T14%3A55%3A13IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Issues%20to%20Be%20Addressed%20and%20Hopefully%20Resolved%20in%20the%20Carotid%20Revascularization%20Endarterectomy%20Versus%20Stenting%20Trial%202&rft.jtitle=Angiology&rft.au=Moore,%20Wesley%20S.&rft.date=2016-05&rft.volume=67&rft.issue=5&rft.spage=408&rft.epage=410&rft.pages=408-410&rft.issn=0003-3197&rft.eissn=1940-1574&rft_id=info:doi/10.1177/0003319715611281&rft_dat=%3Cproquest_cross%3E1781536367%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1781536367&rft_id=info:pmid/26460327&rft_sage_id=10.1177_0003319715611281&rfr_iscdi=true